Codes ATC:
L01XX02
EMLc
Indication
Lymphoid leukaemia, not elsewhere classified
Code ICD11:
2C03.3
Type de médicament
Biological agent
Type de liste
Liste de base
(EML)
(EMLc)
(EMLc)
Formulations
Parenteral > General injections > unspecified:
10000 IU in vial powder for injection
Historique des statuts LME
Ajouté pour la première fois en 2015
(TRS
994)
Sexe
Tous
Âge
Aussi recommandé pour les enfants
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite
sur les brevets.
Résumé des preuves et recommandation du comité d'experts
In 2015, as part of the comprehensive review of cancer medicines undertaken by the Expert Committee, listing for asparaginase on the complementary list of the EML and EMLc for use in treatment protocols for acute lymphoblastic leukaemia (ALL) was recommended. The relevant extract from TRS994 regarding the Expert Committee's 2015 consideration of treatment protocols for ALL is attached.